ORI has released two notice of funding opportunity announcements for projects, conferences, and workshops that advance the evolving field of research integrity and produce tangible outcomes related to ensuring the integrity and reliability of Public Health Service funded research.

The ORI FY 2022 Annual Report is now available.

The Office of Research Integrity is seeking highly qualified candidates for two positions: a Scientist-Investigator position within the Division of Investigative Oversight and an Education and Integrity Specialist position within the Division of Education and Integrity.

We are pleased to announce that Sheila Garrity, JD, MPH, MBA will be joining ORI in March as the new Director.

ORI found that Alice C. Chang, Ph.D. (formerly named Chun-Ju Chang), who was an Associate Professor of Basic Medical Sciences, College of Veterinary Medicine, PU, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH).

ORI found that Douglas D. Taylor, Ph.D. (Respondent), former Professor and Vice Chair for Research, Department of Obstetrics & Gynecology, UL, engaged in research misconduct under 42 C.F.R. Part 93 in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH).

ORI found that Romina Mizrahi, M.D., Ph.D., who was a Clinician Scientist, Positron Emission Tomography Centre, CAMH, and an Associate Professor, Department of Psychology, University of Toronto, engaged in research misconduct in research reported in a grant application submitted for U.S. Public Health Service (PHS) funds, specifically National Institute of Mental Health (NIMH), National Institutes of Health (NIH).